ReviewFrontiers in immunology2025

B-cell-driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review.

Pietro Antonio Bruno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.